News

Results: Average gastric emptying rate, amplitude of antral contractions and antral motility index were lower in patients (46.5%, 74.3% and 6.5 respectively) compared to controls (66.17%, 89% and ...
The antrum grinds and sieves solids, ... Acute hyperglycemia is itself a reversible cause of delayed gastric emptying, leading to reduced fundic tone, suppression of antral contractions, ...
This gastric emptying test would be done for clinical evaluation and is not part of the research study. From these participants with gastroparesis symptoms, we will include those with delayed gastric ...
This study was aimed to investigate the association of restriction fragment length polymorphisms (RFLPs) for pepsinogen genes with peptic ulcer disease. Eighty unrelated controls, 61 patients with ...
Several studies have demonstrated that more extensive GIM correlates with increased gastric adenocarcinoma risk.32 36–38 Of note, a Columbian study found that in comparison with focal or ...
A peptic ulcer is an open sore found on the lining of the stomach or duodenum (the first part of the small intestine). A gastric ulcer is located in the lining of the stomach. A: X-ray of gastric ...
DM was induced with streptozotocin and a high-fat, high-sugar diet for 6 weeks. The DM + TT group received tuina therapy (20 min/session, 5 times/week) for 6 weeks. Weekly random blood glucose, ...
Pediatric gastric emptying (standardized meals, imaging protocols, and reference study values have yet to be established) Importance of other aspects of gastric motility such as fundal–antral ...
Perioperative FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) is a standard therapy for resectable gastric and gastroesophageal junction adenocarcinomas, but recurrence rates remain ...
On the basis of phase 2 studies, trastuzumab deruxtecan was approved for patients with human epidermal growth factor receptor 2 (HER2)–positive metastatic gastric cancer or gastroesophageal ...
CHICAGO — Second-line trastuzumab deruxtecan-nxki significantly extended OS compared with paclitaxel plus ramucirumab for patients with advanced gastric cancers previously treated with ...